Following the update, Glucotrack stock traded over 12% higher in Thursday’s premarket. New Patents Strengthen IP The US ...

In recent years, diabetes management has undergone a remarkable transformation with the rise in continuous glucose monitors (CGMs). These devices present patients with an easier way to maintain ...

The MIT team used Raman spectroscopy—a technique that reveals the chemical composition of tissues by shining near-infrared or visible light on them—to develop a shoebox-sized device that can measure ...

Glucotrack, Inc. (Nasdaq: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

RUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel ...

Introduced in the late 1990s, continuous glucose monitoring (CGM) revolutionized diabetes care. Prior to CGM, home blood glucose monitoring (BGM) methodologies – which involve patients using a lancet ...

At the 18th International Diabetes Federation Congress (IDF) symposium on "Insulin Delivery Devices and Glucose Sensors," [1] Theodor Koschinsky, MD, University of Dusseldorf, Germany, discussed the ...

Feasibility study underway for the Company’s novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks Rutherford, NJ, Dec. 03, 2024 (GLOBE NEWSWIRE) -- ...

Investing.com -- Glucotrack Inc. (NASDAQ:GCTK) stock surged 60% Thursday after the company announced that the U.S. Patent and Trademark Office (USPTO) has approved three patents for its continuous ...

Estimates from the International Diabetes Federation indicate that in 2021, the number of adults with diabetes in South and Central America was about 341 million. In Brazil, according to data from the ...